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This article represents the sixth annual review of
the current state of pediatric transplantation in the
United States from the Scientific Registry of Trans-
plant Recipients (SRTR). It presents updated trends,
discussion of analyses presented during the year by
the SRTR to the committees of the Organ Procure-
ment and Transplantation Network (OPTN) and dis-
cussion of important issues currently facing pediatric
organ transplantation. Unless otherwise stated, the
statistics in this article are drawn from the refer-
ence tables of the 2007 OPTN/SRTR Annual Report.
In this article, pediatric patients are defined as can-
didates, recipients or donors aged 17 years or less.
Data for both graft and patient survival are reported
as unadjusted survival, unless otherwise stated (ad-
justed patient and graft survival are available in the
reference tables). Short-term survival (3 month and
1 year) reflects outcomes for transplants performed in
2004 and 2005; 3-year survival reflects transplants from
2002 to 2005; and 5-year survival reports on transplants
performed from 2000 to 2005. Details on the methods
of analysis employed may be found in the reference
tables themselves or in the technical notes of the 2007
OTPN/SRTR Annual Report, both available online at
www.ustransplant.org.
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Pediatric Organ Donors
Organ donation in the pediatric population has declined
somewhat in the past 10 years, both in absolute numbers
(from 1056 in 1997 to 966 in 2006) and in percentage of to-
tal donors (from 19.3% in 1997 to 12.0% in 2006). The dis-
tribution of pediatric donor ages has remained consistent,
with close to 60% between the ages of 11 and 17. Among
deceased donors of kidneys, the number and percentage
of pediatric donors declined between 1997 and 2006 (from
967 to 886 and from 19.0% to 12.3%, respectively). The
age distribution of pediatric kidney donors has remained
consistent. The number of pediatric pancreas donors grew
from 305 in 1996 to 388 in 2006, while the percentage
of pediatric donors declined from 23.1% to 19.2%. The
age distribution has fluctuated somewhat, but the largest
group of pediatric pancreas donors has been among ages
11–17 (81–89% each year). While the total number of liver
donors has increased over the past 10 years, the number of
pediatric liver donors has decreased from 939 to 860 (from
20.4% to 12.3%). As with other organs, donors age 11–17
make up the largest fraction of pediatric liver donors. The
number of pediatric intestine donors has increased from
58 to 128, but no consistent trend in percentage has been
observed. The number of pediatric heart donors has de-
clined from 585 to 474 (from 24.1% to 20.8%), whereas
the number of adult heart donors has remained steady.
There is no apparent trend in the absolute number of pe-
diatric lung donors, but the percentage of pediatric lung
donors has declined from 22.7% to 15.8%.
While the number of adult donors is significantly greater
than the number of pediatric donors, the percentage of or-
gans transplanted versus organs recovered from deceased
donors is generally greater within the pediatric age range,
even when the analysis is restricted to young and middle
age adults (donors aged 18 to 49 years). For deceased kid-
ney donors, 94.7% of the pediatric kidneys recovered were
transplanted while 91.6% of the kidneys recovered from
donors age 18 to 49 years were transplanted. There was a
similar trend for pancreas donors (81.4% vs. 72.2%), liver
donors (96.0% vs. 91.4%) and intestine donors (94.7%
vs. 85.7%). With heart and lung donors, the percentage of
organs transplanted that were recovered is high and sim-
ilar for both pediatric donors and adult donors aged 18 to
49 years (98.9% vs. 99.0% for heart and 98.1% vs. 96.4%
for lung) (SRTR Analysis December 2007).
The ever present shortage of deceased donors has led to a
broad range of efforts to increase donation, including dona-
tion after cardiac death (DCD). Over the last decade, DCD
has increased across all age ranges; from 78 in 1997 to
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647 in 2006 (1.4% to 8.1%, respectively). In the pediatric
population, the number of DCD donors increased from 6
to 77. Less than 1% of the pediatric donors were DCD
in 1997; in 2006, approximately 8% of pediatric donors
were DCD. While the relative percentage of DCD donors
is similar in both the adult and pediatric population, there
is likely an unmet potential of DCD in the pediatric popula-
tion (1). Recent policies advanced by both The Joint Com-
mission (JCAHO) and the Organ Procurement and Trans-
plantation Network (OPTN) requiring hospitals to develop
and implement DCD policies have refocused interest on
DCD. In moving forward with policy development, many
institutions have faced challenges related to the fact that
DCD is relatively unfamiliar in pediatric ICUs, where well-
developed end-of-life and withdrawal of support practices
already exist. Additionally, the relatively small numbers of
pediatric DCD donors and transplant recipients within any
hospital make informed discussion of the challenges and
solutions more problematic.
It is important for the pediatric transplant community to ac-
tively engage those involved in end-of-life care for children
and to provide perspective and guidance. Developing and
sharing best practice models for pediatric DCD may help.
As a step forward, the Health Resources and Services Ad-
ministration (HRSA), the Organ Donation and Transplanta-
tion Alliance and the United Network for Organ Sharing
(UNOS) sponsored a Pediatric Summit on Organ Donation
and Transplantation in San Antonio, Texas in March 2007.
This summit brought together members of the pediatric
ICU and transplant communities to discuss solutions to fa-
cilitate donation in the pediatric population. This effort will
hopefully enhance inter-disciplinary dialogue and assist in-
stitutions in developing pediatric DCD programs. While ef-
forts to increase DCD are worthwhile because they will re-
sult in more donors, it is also important to realize that DCD
provides the family of a child contemplating withdrawing
life support because of irreversible neurologic injury the
opportunity to pursue organ donation, if that is their wish.
Overall Pediatric Waiting List
The total number of pediatric candidates on the waiting
list at a given point in time increased steadily from 1739
in 1997 to a peak of 2340 in 2001 and has since lev-
eled, with 2124 candidates in 2006 (Figure 1). Distribu-
tion by age of pediatric candidates on the waiting list
has remained consistent, averaging 6.6% aged less than
1 year, 26.9% 1–5, 19.8% 6–10 and 46.7% 11–17 years.
The overall percentage of pediatric candidates on the wait-
ing list has declined somewhat, from 3.3% in 1997 to 2.3%
in 2006.
The number of pediatric candidates active on the liver wait-
ing list increased steadily in the late 1990s to a peak of 703
in 2001. It then dropped to 537 in 2002 and has since de-
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Source: 2007 OPTN/SRTR Annual Report, Table 1.4.
Figure 1: Pediatric transplant waiting list (active and inactive)
at year-end for all organs, by age, 1997–2006.
that of the number of adults on the liver waiting list. Data
regarding the kidney waiting list were similar in both trend
and number: after a steady increase, the number of candi-
dates peaked at 645 in 2002, then dropped to 559 in 2003
and dropped further to 422 in 2006.
The number on the intestine waiting list almost tripled over
the decade, from 53 in 1996 to 140 in 2006. There has been
no obvious trend in the number of active pediatric candi-
dates on the heart waiting list, with about 85–110 waiting
at the end of each year. The total number of candidates
of any age on the heart waiting list decreased from 2414
in 1997 to 1327 in 2006. The active pediatric candidates
on the heart waiting list made up only 3.5% of the waiting
list in 1997; this percentage had increased to about 8%
in 2006. The number of pediatric candidates on the lung
waiting list was nearly constant (approximately 130 each
year) between 1997 and 2004, but dropped to 77 in 2005,
which further dropped to 42 in 2006. The changes in the


















Kidney Liver Intestine Heart Lung
Source: 2007 OPTN/SRTR Annual Report, Tables 5.1a, 9.1a, 10.1a, 11.1a, and 12.1a.
Figure 2: Distribution of active pediatric waiting list candi-
dates at year-end, by organ, 1997–2006.
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Pediatric Transplant Recipients
Over the last 10 years, the number of pediatric recipients
of any organ grew 20% (from 1648 to 1979), in contrast to
the 44% increase in the number of adult recipients (from
18 657 to 26 951). The greatest increase, 35%, occurred in
the largest group, recipients 11–17 years old (648 in 1997 to
876 in 2006). The remaining pediatric groups experienced
increases of smaller proportion: recipients < 1 year old
increased 13% (278 to 313) and recipients 1–5 years old
increased 16% (447 to 517). The number of transplants in
the 6- to 10-year olds decreased by 1% from 275 in 1997
to 273 in 2006. As on the waiting list, the age distribution
among transplant recipients has remained consistent at
about 16% under 1 year, 26% 1–5 years, 16% 6–10 years
and 42% 11–17 years. The proportion of pediatric patients
among recipients has declined by approximately 15% from
8.1% in 1997 to 6.8% in 2006.
Kidney Transplantation
Kidney transplantation is well accepted as the optimal ther-
apy for children with end-stage renal disease (ESRD). In
efforts to prioritize allocation to children awaiting kidney
transplantation, over much of the last decade the gener-
ally agreed-upon underlying principle regarding deceased
donor allocation has been to try to transplant children
from 0 to 6 years old within 6 months, children from 7 to
12 years within 12 months and patients 12 to 18 years
within 18 months. While this resulted in shorter waiting
times for children compared to adults, it still required a wait-
ing period. As these children still received relative priority,
this approach conferred little benefit to anyone awaiting
transplantation. Additionally, once these time goals were
reached, it was common practice for centers to wait for
better donor offers, further compounding the waiting time.
A Scientific Registry of Transplant Recipients (SRTR) anal-
ysis, performed in conjunction with the OPTN Kidney-
Pancreas Committee, demonstrated that the characteris-
tic most associated with improved outcomes in deceased
donor pediatric transplantation was donor age between 5
and 35 years (2). Consequently, in 2005 the OPTN imple-
mented a pediatric kidney allocation policy under which rel-
ative priority for kidneys from deceased donors less than
35 years old was assigned to recipients less than 18 years
old, after any zero mismatch transplants, recipients with a
PRA > 80, or candidates receiving a kidney with a nonrenal
organ (3).
One anticipated effect of this policy is a reduction in de-
ceased donor waiting time for pediatric recipients. While
pediatric candidates have always had significantly shorter
waiting times compared to adults, there has been a further
reduction in median waiting times observed following im-
plementation of this policy (Figure 3). This effect is most
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Source: 2007 OPTN/SRTR Annual Report, Table 5.2.
Figure 3: Median time to transplant for new kidney transplant
waiting list registrants, by age, 1997–2006.
ing the longer waiting times in these older children under
the previous time-based targets. Because these times to
transplant are based on year of listing, the new policy has
affected recipients listed in the years prior to its imple-
mentation. It is unknown where the new median time to
transplant will reequilibrate.
While there has been a reduction in waiting time, there
has been little change in the age distribution of pediatric
candidates on the kidney waiting list. Additionally, children
on the kidney waiting list have consistently had the lowest
death rates with a rate of about 10 deaths per 1000 patient-
years in 2006.
While the new allocation policy appears to have signifi-
cantly increased access for deceased donor kidneys, it may
also be contributing to a change in practice in living donor
and deceased donor transplantation (Figure 4). Over most
of the last decade, living donor transplants accounted for
slightly more kidney transplants to pediatric recipients than
deceased donor, non-expanded criteria donor (ECD) trans-
plants. This changed in 2005, when there were 422 living
donor transplants and 468 deceased donor, non-ECD trans-
plants. This difference further widened in 2006, when there
were 312 living donor compared to 581 deceased donor,
non-ECD transplants. Pediatric kidney recipients are rarely
transplanted with ECD kidneys. There was only one such
pediatric recipient in 2006.
In the past decade, there has been a 2-fold increase in the
number of deceased donor non-ECD transplants to pedi-
atric recipients. In 2006 alone, the number of these trans-
plants to pediatric recipients increased 24% to 581, from
468 in 2005. There is great concern that this most recent
increase in deceased donor transplantation is a result of
the higher priority granted for deceased donors, which has
resulted in a reduction of living donor transplantation. Al-
though there were increases in the number of deceased
donor transplants to children 6–10 and <5 years old, most
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Source: 2007 OPTN/SRTR Annual Report, Table 5.2.
Figure 4: Pediatric kidney transplant recipients by donor type,
1997–2006.
of the absolute increase is attributable to a 25% increase in
deceased donor transplants to the 11–17 group (Figure 5).
Additionally, it appears that the recent shift from living
donors to deceased donors is primarily a phenomenon
affecting these older children. It is likely that at least some
of this apparent shift reflects a ‘bolus effect’ of deceased
donor transplants in these older children, and is reflective
of higher allocation priority rather than an exclusive change
in practice patterns to not pursue living donation. However,
no doubt there have also been instances where a child was
listed while living donors were being evaluated and a de-
ceased donor became available. Whether this trend will
continue remains to be determined. Given the increased
availability of deceased donor kidneys, pediatric centers
may need to alter listing practices while potential living
donors are being evaluated. One would hope that given
the better results following living donor transplant, centers
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Closed symbol = living donor; open symbol = deceased donor, non-ECD. 
Source: 2007 OPTN/SRTR Annual Report, Table 5.4a and 5.4c.
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Source: 2007 OPTN/SRTR Annual Report, Table 5.10a.
Figure 6: Unadjusted graft survival of deceased donor non-
ECD kidney transplants, by recipient age.
Outcomes following pediatric kidney transplantation are
highly dependent on donor source (Figure 6 and
Figure 7). Overall, living donor pediatric kidney recipients
had better unadjusted 1-, 3- and 5-year graft survival than
the deceased donor, non-ECD recipients. Three-year graft
survival was markedly higher for living donor recipients
compared to deceased donor, non-ECD recipients for pe-
diatric recipients 1–5 years old (93% vs. 82%), 6–10 years
old (92% vs. 82%) and 11–17 years old (85% vs. 76%). The
graft survival advantages associated with living donor re-
cipients was even greater in 5-year graft survival across pe-
diatric recipients 1–5 years old (89% vs. 75%), 6–10 years
old (85% vs. 72%) and 11–17 years old (74% vs. 63%).
Consistent with previous reports, while short-term results
are excellent in the 11- to 17-year-olds, there is a significant
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Source: 2007 OPTN/SRTR Annual Report, Table 5.10c.
Figure 7: Unadjusted graft survival of living donor kidney
transplants, by recipient age.
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While some worry that the recent policy changes providing
greater access to deceased donors will lower the likelihood
of a highly matched kidney, Gritsch et al. independently
reported that, except for zero mismatched allografts, the
impact of HLA matching in deceased donor pediatric kid-
ney transplantation was minor (5). While it is likely this find-
ing will remain consistent for recipients of deceased donor
kidneys following the policy change, the follow-up time is
insufficient to conduct a meaningful analysis of long-term
outcomes. Nonetheless, it is likely that given the better
outcomes following living donor transplants compared to
deceased donors, any practice associated with an increase
in deceased donor transplants may actually decrease over-
all graft survival across the population.
With respect to patient survival, there were no striking dif-
ferences for living donor recipients in the different pedi-
atric age groups, with 5-year survival in the range of 94.7–
96.3%. Patient survival rates in living donor kidney recipi-
ents were slightly better for the 6- to 10-year-olds and 11-
to 17-year-olds compared to the 1- to 5-year-olds. Unad-
justed patient survival for deceased donor, non-ECD recipi-
ents was slightly lower than that of living donor recipients.
While recipient survival is excellent, there remains a real
risk of mortality, which has not changed significantly over
recent years. The number of patients living with a func-
tioning kidney transplant who received their transplants as
children increased over the decade to 5338 recipients in
2005.
Liver Transplantation
The number of patients of all ages who are active on the
liver waiting list increased from 7571 in 1997 to a peak of
14 893 in 2001 and has leveled off at about 12 500 since
then. The number of pediatric patients on the waiting list
grew steadily from 492 in 1997 to a peak of 703 in 2001 and
has since declined to 361 in 2006. The pediatric patients
on the waiting list now make up a much smaller proportion
of the list (2.9% compared to 6.5% in 1997) because of
the overall growth on the list.
Pediatric liver candidates account for a greater percent-
age of all candidates who are inactive on the liver wait-
ing list (8.9%) compared to those active (2.9%) on the
liver waiting list in 2006. At the end of 2006, 48.6% of
pediatric candidates were active, compared to 75.6% of
adult candidates. The reasons why there are significant
numbers of pediatric candidates inactive at any given time
compared to adult candidates is unknown. The numbers
and percentage of both pediatric and adult liver transplant
candidates that were inactive at the end of 2006 is sum-
marized by OPTN region in Table 1. There is evidence
of significant regional variation, which may reflect center-
specific practices. These findings are worthy of further
investigation.
Table 1: Inactive pediatric and adult liver transplant candidates as
of 31 December 2006, by OPTN region
Pediatric Adult
n % n %
Overall 382 51.4 3931 24.4
Region 1 24 80.0 438 42.9
Region 2 24 13.3 542 24.3
Region 3 11 25.0 178 19.3
Region 4 20 55.6 290 19.6
Region 5 174 77.3 790 20.3
Region 6 6 42.9 74 19.2
Region 7 42 66.7 295 19.4
Region 8 21 53.8 211 23.9
Region 9 38 69.1 536 28.9
Region 10 9 27.3 178 23.2
Region 11 13 56.5 399 34.2
The death rate for pediatric candidates on the liver waiting
list is highly dependent on age (Figure 8). While children
above 6 years of age have equivalent or slightly lower death
rates compared to adults, younger children have the high-
est death rates of all candidates. Additionally, it appears
that for the last 2 years, the death rate while awaiting trans-
plantation may be increasing in children less than 6 years
of age. While the small numbers of events make analysis
difficult, there were 103 pediatric candidates who died in
2006 prior to transplantation.
Recent allocation changes in liver transplantation most rel-
evant to the pediatric population include the use of model
for end-stage liver disease (MELD) rather than pediatric
end-stage liver disease (PELD) for allocation in adolescent
candidates, and the refinement of the criteria for Status 1
listing, with the creation of Status 1A and 1B for pediatric
candidates. These Status 1 designations were accompa-
nied by more rigorously defined criteria for who qualifies for
listing under each status. Status 1B is reserved for pediatric
candidates with chronic liver disease who are in the ICU
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Source: SRTR Analysis, June 2007.
Figure 8: Reported pediatric liver only (no intestine) waiting
list annual death rates per 1000 patient-years at risk, 1997–
2006.
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score of >25 for adolescent candidates (12–17 years) and
are also on a ventilator, mechanical ventilator, have had gas-
trointestinal bleeding requiring at least 30 cc/kg of red blood
cell replacement within the previous 24 hours, have renal
failure requiring dialysis, or have a Glasgow coma scale <
10. One factor in the decision to allow children with chronic
liver disease to be listed as a Status 1B was based on an
SRTR analysis that showed that when these children had
a PELD score > 25 and were listed as a Status 1 by excep-
tion, their observed mortality rate was significantly higher
than reflected by their PELD score alone.
While the use of MELD for adolescent candidates was
shown in an SRTR analysis to usually result in a higher allo-
cation score than they would receive using PELD, demon-
strating any significant impact on outcomes due to this
change will be difficult given the relatively limited size of
this group. Similarly, the small number of pediatric patients
listed as Status 1B to date limits the ability to demonstrate
any significant impact on outcomes. In 2006, the first full
year after the policy change, there were 46 liver transplants
performed for Status 1 B recipients. After several years of
experience, a more in-depth analysis may be possible.
As noted in the intestine section, there are efforts to fur-
ther refine liver allocation and preferentially allocate from
the smallest deceased donors to candidates listed for liver-
intestine transplantation over liver alone due to a high risk
of waiting list mortality in the liver-intestine population that
is not well reflected by their PELD score. While it is hoped
that such efforts will decrease mortality in the small chil-
dren awaiting liver-intestine transplantation, it is possible
that this preferential allocation will adversely affect the
waiting list mortality rate in the youngest candidates await-
ing liver transplantation, a sub-population that also faces
a disproportionately high mortality rate. While candidates
awaiting liver transplantation alone have the potential to
receive technical variant grafts from either deceased or liv-
ing donors, it is unknown if this option will be sufficient. It
is clear, based on a previous analysis, that the use of de-
ceased donor technical variant grafts is associated with a
higher risk of graft failure and mortality compared to whole
organ grafts (6,7).
The number of deceased and living donor liver transplants
to pediatric candidates has been reasonably constant, with
511 deceased donor and 64 living donor transplants in
2006 (Figure 9). The introduction of adult-to-adult living
donor liver transplantation has significantly impacted who
receives a living donor liver transplant. In 1998, the percent-
age of all living donor liver transplants that went to adults
was about 27%; in 2006, the reverse was true, and 22% of
living donor liver transplants went to pediatric candidates.
Unadjusted graft survival at 1 year for pediatric living donor
liver recipients under 6 years of age was better than de-
ceased donor liver recipients (for < 1-year-olds: 88% vs.
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Source: 2007 OPTN/SRTR Annual Report, Tables 9.4a and 9.4b.
Figure 9: Pediatric recipients of deceased and living donor
liver transplants, 1997–2006.
graft survival at 3 years was also slightly better for those
who received living donor livers than for recipients of de-
ceased donor livers (for < 1: 83% vs. 80%; for 1–5: 79%
vs. 76%).
The last decade has seen significant progress in pediatric
liver transplantation, as evident by evaluation of the death
rates in the first year following transplantation (Figure 10).
While there has been improvement in survival across all
ages, the improvement is most striking in the children less
than 1 year of age. As another example of progress, there
have been no deaths in the first year posttransplant in the
83 recipients with a diagnosis of biliary atresia who under-
went living donor transplantation over the last 3 years.
Among deceased donor pediatric recipients, patient sur-
vival at 5 years was highest for the 6- to 10-year-old
group at 89%. Given that the number of liver trans-
plants to adults has increased while the number to pe-
diatric candidates has remained steady, it is not surpris-
ing that, though the number of pediatric (at the time
of transplant) recipients alive with a functioning liver
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Source: 2007 OPTN/SRTR Annual Report, Table 9.7a.
Figure 10: Death rates for pediatric recipients during first year
after deceased donor liver transplantation, 1997–2005.
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proportion of the overall population with functioning liver
transplants has decreased from 15.1% to 12.6%.
Intestine Transplantation
The number of pediatric candidates on the intestine wait-
ing list almost tripled over the decade, from 53 in 1997
to 140 in 2006, and children remained at a consistent pro-
portion, making up about 77% of the overall list. In 2006,
42.8% of pediatric intestine candidates were listed for in-
testine alone compared to 61.9% for adult candidates. The
higher rate of listing for liver-intestine transplantation in the
pediatric age range may reflect differences in the primary
diagnosis leading to the need for intestine transplantation.
Annual death rates on the intestine waiting list have varied
extensively, and the rate is highly dependent on the rel-
ative number of candidates awaiting liver-intestine trans-
plantation. For candidates listed initially for intestine alone,
across all age ranges the death rate in 2006 was 379 per
1000 patient-years. The number of children dying while
awaiting intestine transplantation has remained constant.
The number of intestine transplants to pediatric recipients
has increased about 200% from 46 in 1997 to 95 in 2006.
This trend is seen in all the pediatric age groups, the most
significant increase being in the number of <1-year-olds re-
ceiving intestine transplants. Five-year graft survival is poor
for intestine recipients, at 39% for < 1-year-olds, 54% for
1- to 5-year-olds, 45% for 6- to 10-year-olds and 48% for
11- to 17-year-olds. Patient survival at 5 years was 48% for
< 1-year-olds, 58% for 1- to 5-year-olds, 70% for 6- to 10-
year-olds and 67% for 11- to 17-year-olds (Figure 11). Graft
and patient survival rates for pediatric intestine recipients
at 1, 3 and 5 years improved with increasing age. Among
the pediatric intestine transplant recipients, 11- to 17-year-
olds had the best graft and patient survival rates. At the
end of 2005, there were 311 pediatric intestine recipients
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Source: 2007 OPTN/SRTR Annual Report, Table 10.14.
Figure 11: Unadjusted patient survival at 3 months, 1 year,
3 years and 5 years following intestine transplant, by age.
Previous reports have discussed in detail the high death
rate for candidates awaiting intestine transplantation and
how these candidates seem less well served by PELD or
MELD compared to liver alone candidates (4,8). Recent al-
location changes have included giving pediatric candidates
listed for liver-intestine transplantation a 23-point increase
in their PELD or MELD score. Other considerations are
policies that may direct small donor livers (if suitable for
use as a composite allograft with intestine) to the infants
listed for both organs rather than to children requiring a
liver transplant alone.
Heart Transplantation
Although the number of candidates on the heart waiting
list has decreased from 2414 in 1997 to 1327 in 2006,
the number of pediatric candidates has been nearly con-
stant, with 106 active on the waiting list at the end of
2006. The number of new pediatric heart registrants by
age category has also remained relatively constant (Fig-
ure 12). While the number of new pediatric registrants
on the heart waiting list has shown no consistent trend,
the number of transplants to pediatric recipients has in-
creased marginally, from 277 in 1997 to 314 in 2006
(Figure 13). The number of pediatric deaths on the waiting
list has decreased to only 59 deaths in 2006, bringing the
death rate to 89 per 1000 patient-years, compared to the
2005 death rate of 122 per 1000 patient-years. One-year
patient survival for pediatric heart recipients increased with
increasing age from 81% for <1-year-olds to 91% for 11- to
17-year-olds (Figure 14). Among the pediatric heart trans-
plant recipients, the 6- to 10-year-olds had the best 5-year
patient survival rates at 81%. The prevalence of pediatric
heart recipients living with a functioning graft followed the
overall trend of the prevalence of all heart recipients, in-
creasing steadily from 1369 at the end of 1997 to 2246 at
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Source: 2007 OPTN/SRTR Annual Report, Table 15.3.
Figure 12: New pediatric registrants on the heart waiting list,
by age, 1997–2006.
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Source: 2007 OPTN/SRTR Annual Report, Tables 11.3, 11.4, and 15.3.
Figure 13: New pediatric heart waiting list registrants, deaths
on the waiting list and transplants, 1997–2006.
Until recently, deceased donor hearts were allocated locally
before being offered out regionally, irrespective of medical
urgency. In 2006, the OPTN Board of Directors approved
a new policy where deceased donor hearts would be
offered to Status 1A and 1B candidates, first locally and
then within Zone A (centers within 500 miles) prior to be-
ing offered locally to Status 2 candidates. The new policy
also incorporated an element of pediatric preference for
pediatric donors. The policy was implemented on 12 July
2006. While a complete evaluation of the impact of this pol-
icy change will require more follow-up, an initial analysis of
741 pediatric heart candidates spanning the pre- and post-
policy implementation periods suggests that the allocation
changes have been beneficial, with a reduction in waiting
list mortality following implementation of the policy (HR =
0.73, p < 0.09) (SRTR Analysis, October 2007).
The progress in pediatric cardiac surgery over the decade
has helped shape the candidate population. Indications for
pediatric heart transplant have changed as surgery for com-
plex congenital heart lesions has evolved (9). These and
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Source: 2007 OPTN/SRTR Annual Report, Tables 11.10 and 11.14.
Figure 14: Unadjusted 1- and 5-year graft and patient survival
of heart transplants, by recipient age.
gather expert opinion to critically reassess the indications
for heart transplantation (10).
Waiting list mortality remains high, particularly in the small-
est children. The lack of suitable ventricular assist devices
for use in infants as a bridge to transplantation has been
a contributor to waiting list mortality in small children. Re-
cent progress in the area has raised the possibility that such
devices may become more readily available (9,11).
In an effort to decrease waiting list mortality, the OPTN
Pediatric committee has focused on broader sharing of pe-
diatric donor hearts. Because donor size is critical in these
smaller candidates, an appropriately sized donor may be
separated by great distance from the recipient. Every ef-
fort should be made to maximize recovery of the hearts
from these donors. One approach is broader sharing. Addi-
tionally, aggressive efforts at donor resuscitation and care-
ful reevaluation over time may yield more suitable donors
than previously realized (12).
An additional effort to improve waiting list survival in the
smallest children is based on the observation that children
under 1 year of age could be successfully transplanted with
an ABO incompatible heart (13). After a careful review of
the available data (8), the OPTN Board voted in 2006 to
allow ABO incompatible heart transplants in children up to
age 2, with careful pre-transplant screening and posttrans-
plant follow-up.
The progress in survival following heart transplantation has
allowed some shifting of focus to long-term health out-
comes. One of the greatest concerns is the progressive
decline in renal function seen late after heart transplanta-
tion with the current calcineurin inhibitor-based immuno-
suppressive regimens. Using OPTN/SRTR data, Lee et al.
studied pediatric heart recipients in the United States from
1990 to 1999 who survived at least 1 year after transplant
and found a 10-year actuarial risk of 4% for developing
ESRD (defined as chronic dialysis and/or kidney transplant)
and a 10-year actuarial risk of 12% for developing chronic
renal insufficiency (CRI, defined as creatinine >2.5 mg/dL,
including those with ESRD) (14). Those who developed CRI
had nine times the risk of death compared to pediatric heart
recipients without CRI (p < 0.0001). Hypertension is also
common, with an incidence of 47% at 1 year posttrans-
plant (15).
Lung Transplantation
Prior to 2005, the number of pediatric lung candidates on
the waiting list was relatively constant. However, this num-
ber has recently dropped precipitously from 131 in 2004 to
77 in 2005 to 42 in 2006 (Figure 15). The number of total
lung candidates of all ages reduced drastically (by almost
50%) in the past 2 years, as well, from 2163 in 2004 to
1032 in 2006.
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Source: 2007 OPTN/SRTR Annual Report, Tables 12.1a, 12.3 - 12.4b.
Figure 15: Pediatric patients listed for lung transplant, deaths
on the waiting list and transplanted, 1997–2006.
A significant change in lung allocation policy was imple-
mented in May 2005. Prior to that time the allocation
system was based primarily on waiting time. The new allo-
cation system is centered on the principle of transplant
benefit and medical urgency. The lung allocation score
(LAS) incorporates a prediction of the difference between
the measures of waiting list survival and posttransplant sur-
vival for each candidate, seeking to maximize the 1-year
survival benefit of lung transplantation (16). Additionally, it
seeks to minimize deaths on the waiting list by balancing
the benefit calculation and the degree of medical urgency,
as reflected by waiting list mortality. The new allocation
policies are used to distribute lungs to candidates aged
12 years and older. The decision to include adolescents
with adults was based on analyses suggesting the mortal-
ity risk was very similar. In contrast, children under age 12
have a heterogeneous group of diagnoses, which makes
modeling more difficult. Allocation to these younger chil-
dren continues to be based on waiting time. For both the
younger children and the adolescent candidates, there is
also preferential allocation of pediatric donor lungs.
It is likely that the sharp reduction in the lung candidates
over the last 2 years is a response to this new allocation
policy where waiting time was de-emphasized. The num-
ber of pediatric deaths on the waiting list has gradually
declined over the decade, as well, while the number of
pediatric lung transplants per year had been relatively con-
stant. Potential factors that may contribute to the decline
in waiting list deaths include improvements in the ability
to identify candidates at the highest risk of mortality and
allocate lungs accordingly, refinements in management of
end-stage lung disease and changes in center practice such
as not listing higher risk candidates or removing candidates
at the highest risk of mortality from the waiting list. The
relative distribution of waiting list deaths across the pedi-
atric age groups has stayed constant.
While the total number of lung transplants has grown 54%
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Source: 2007 OPTN/SRTR Annual Report, Table 12.10a.
Figure 16: Unadjusted graft survival at 3 and 5 years for de-
ceased donor lung transplant recipients, by age.
number of pediatric recipients has remained relatively sta-
ble and, consequently, the proportion of lung transplants
to pediatric candidates has decreased: 3.9% of the re-
cipients in 2006 compared to 5.8% in 1997. In 2006,
54 pediatric candidates received lung transplants and 16
died while waiting. The death rate on the lung waiting
list among pediatric candidates has dropped to about 70
deaths per 1000 patient-years at risk in 2006, compared
to an average of 140 deaths per 1000 patient-years in
1997–2001.
The time until 25% of the new registrants have received
a lung transplant has varied widely among pediatric can-
didates over the past decade, from 9 to 156 days for
registrants < 1-year-old, 39 to 279 days for 1- to 5-year-
olds, 93 to 883 days for 6- to 10-year-olds and 40 to 783
days for 11- to 17-year-olds. At 3 years posttransplant,
6- to 10-year-old recipients of deceased donor lung trans-
plants had the best graft survival among the pediatric age
groups, at 81%, followed by < 1-year-olds at 64%, then
1- to 5-year-olds at 70% and 11- to 17-year-olds at 57%
(Figure 16). The deceased donor graft survival rate at 5
years was poor, especially among the 11- to 17-year-olds
at 24%.
At the end of 2005, 237 (4%) of the 5684 people alive with
functioning lung transplants had received their transplants
as children.
Waiting list mortality has typically disproportionately af-
fected pediatric candidates, though the finding has de-
creased in magnitude recently (Figure 17). Many efforts
continue to be directed toward the problem of waiting list
mortality. There are potential donor lungs that go unuti-
lized. Continued focus on optimizing the management of
all donors with the goal of lung donation can have a large im-
pact on the potential number of donor lungs (17). Broader
geographic sharing is also likely to better match up the ap-
propriate donor with the appropriately sized candidate. Fi-
nally, better prioritization with respect to medical urgency is
also likely to have an impact. As mentioned previously, the
current LAS system does not apply to children less than















Source: 2007 OPTN/SRTR Annual Report, Tables 12.3 -12.4b.
Figure 17: Ratio of lung waiting list deaths to transplants,
pediatric and adult, 1997–2006.
12 years of age. Efforts to develop a LAS system in
this population are hindered by the small numbers of
candidates but incremental progress is possible. As one
attempt to evaluate factors related to waiting list mor-
tality, the SRTR evaluated 175 candidates less than
12 years of age who were listed between 1 Jan-
uary 2001 and 1 January 2003. Factors associated with
an increased risk of waiting list death in a univariate
analysis included being hospitalized (HR = 2.69, p =
0.0045), being in the ICU (HR = 4.66, p < 0.0001),
and being on a ventilator (HR = 4.15, p = 0.0002).
Mean PA pressure did not reach statistical significance
(HR = 1.02, p = 0.1044) but it was not available in many chil-
dren (SRTR Analysis, June 2007). It seems some type of
urgency criteria can be developed to replace waiting time,
which may get the most urgent candidates transplanted.
Pediatric lung transplantation has made significant
progress but challenges remain (18). Outside the im-
mediate postoperative period, infection accounts for half
the deaths observed. At 1-year posttransplant, bronciolitis
obliterans is the leading cause of death (19).
Pediatric Transplantation: Common Themes
While there are substantial differences across specific or-
gan systems, there are also common themes across pe-
diatric transplantation worthy of reflection. An overarch-
ing theme of the OPTN Pediatric Committee has been the
charge to eliminate waiting list death in children. In liver,
intestine and heart transplantation, mortality rates in the
youngest candidates remain unacceptably high. Many ef-
forts are needed to eliminate waiting list death. Encour-
aging donation in the pediatric population is important.
We must develop protocols to ensure all potential trans-
plantable organs are utilized.
Broader geographic sharing accomplishes many goals, in-
cluding helping reduce waiting list mortality. Broader shar-
ing of the young pediatric donor may provide a better match
between the need for these organs and the availability of
such donor organs, especially when combined with alloca-
tion priorities not based on waiting time.
Another theme is the profound effect changes in alloca-
tion can exert. In kidney transplantation, relative prioriti-
zation for donors less than 35 years of age has led to a
substantial decrease in waiting times for pediatric candi-
dates. One potential unintended consequence of this in-
creased priority is a decrease in the numbers of living donor
transplants performed. Additionally, the removal of wait-
ing time goals for pediatric recipients may be adversely
affecting the highly sensitized pediatric recipient who now
may have decreased access to the larger pool of donors
who are above age 35. Efforts are underway to better
evaluate both of these issues. In liver and lung transplan-
tation, a switch from allocation based on waiting time
to one based on urgency has profoundly affected listing
practices.
The impact of growth and development on outcomes re-
mains poorly understood. Graft loss in adolescent recipi-
ents is a problem. Nonadherence is the most commonly
cited factor yet there are other mechanisms, including
physiologic growth and development, which may be in-
volved (20). As pediatric transplant recipients, they have
both a lifetime of hope and a lifetime of care. The fi-
nancial pressures involved, and the impact of finances
on outcomes, should not continue to go unanswered
(21,22).
The final issue concerns data collection. In 2006, the OPTN
embarked on an effort to decrease the data reporting
burden, focusing specifically on areas of redundancy and
on long-term (greater than 5 years posttransplant) follow-
up. It has been estimated that these changes have led
to an approximate 40% reduction in the data reporting
burden. During this process, the pediatric community ex-
pressed concern that much of the benefit of transplanta-
tion in pediatric candidates relates to long-term outcomes
and these data are vital. Additionally, much of the data of
interest in children is different compared to adults. Be-
cause of this, it has been recognized that there are data
elements that need revision to fully serve the pediatric
population. The OPTN Board has been receptive to these
concerns.
While the reporting requirements for pediatric patients re-
main largely intact, there is a clear mandate that alterna-
tive sources of information be explored and supported,
and wherever possible duplication of existing efforts be
avoided. It is noteworthy that there are pediatric-specific
transplant registries (e.g. NAPRTCS or SPLIT) that might
serve as parallel sources of data. In the past, these reg-
istries have played a fundamental role in providing data for
analysis used in the development of pediatric allocation
policy. Future funding for these registries is uncertain and
these data collection efforts may not be able to continue
without partnership with the OPTN. How to best link the
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OPTN data collection needs and the interests of these pe-
diatric registries, and how this effort would be supported,
is worthy of discussion.
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